Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

TCF7L2 gene polymorphism is linked to alopecia areata, but it doesn't affect the success of PRP or conventional treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

BLTP1 and KIF27 gene mutations can help breed better wool sheep.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

A specific gene variation increases the risk of high uric acid and cholesterol in young Mexican males.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Blocking certain immune signals can reduce skin damage from radiation therapy.

The research linked PLCD1 gene variants to the development of trichilemmal cysts.

Certain genetic variations in the A2M gene are linked to better milk quality in Murrah buffaloes.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

A genetic duplication on chromosome 5 was linked to a woman's unique combination of medical conditions.

The number of CAG repeats in the androgen receptor gene doesn't significantly affect female pattern hair loss in the Han Chinese population.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

A new mutation in the ST14 gene broadens the understanding of ichthyosis-hypotrichosis syndrome.

Gene variation affects prostate issues and hair loss.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Certain SPINK5 gene mutations are common in Israeli families with Comèl-Netherton syndrome.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.